This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Dr. Caleb Bates focuses his practice on intellectual property law, with an emphasis on patentprosecution, strategic counseling, and worldwide patent portfolio management in the pharmaceutical and biotechnology fields. with highest honors from the Georgia Institute of Technology in 2009. He received his J.D.,
Baca focuses her practice on IP portfolio management, strategic client counseling, and patentprosecution in diverse scientific and engineering fields. from the University of Pittsburgh School of Law in 2009, and her Ph.D. She received her J.D. from the University of Chicago in the Department of Chemistry in 2005.
Between 2009 and 2013, the rate at which applications subject to the former (i.e. In particular, expedited examination under the Global PatentProsecution Highway (GPPH) program rose from just 2.7% Finally, the most recent data confirms (once again) that the duration of patentprosecution (i.e. in 2019/20.
The Drug and the patent. The international filing date of the patent application for EO is May 21, 2003 and the proprietary right over EO was granted to GlaxoSmithKline LLC in 2009. Therefore, the patent will remain active till May 21, 2023, by the virtue of Section 53 (1) of the Patent Act. Relying on Novartis v.
of the Patent Act has brought about a significant shift in the Canadian approach to file wrapper estoppel by enabling the introduction of a patent’sprosecution history during claim construction. and whether it should cover communications between patentees and foreign patent offices. TA Foods Ltd. 2021 FCA 7 Section 53.1
One pertinent post on this subject was from this month in 2010 called the Patent Eligibility and the Logic of Law and Science. Basheer endorsed the point about testing patent agents on foundational legal subjects since a good part of patentprosecution will involve “legal” aspects, without requiring them to have a law degree to take the exam.
In the Chemtura judgement (2009) concerning section 64(1)(m) (revocation for not furnishing Section 8 information), The Court emphasized on strict interpretation and application of the obligation. The implications of the amended Rules and TEPA are discussed later in the post.) However, in 2014, the Delhi High Court in Sukesh Behl V.
selected address issues such as SPC protection for combination products, double patenting, prosecution history estoppel and the influence of declarations made by the patentee in parallel proceedings, the possibility for national courts to request technical opinions from the EPO under Art. The decisions we (arbitrarily!)
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content